{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:15:12Z","timestamp":1794266112501,"version":"4.9.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.drugalcdep.2020.108255","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T11:05:07Z","timestamp":1598699107000},"page":"108255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study"],"prefix":"10.1016","volume":"217","author":[{"given":"Ingrid Amalia","family":"Havnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bukten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline Borger","family":"Rognli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley Elizabeth","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108255_bib0005","first-page":"J12","article-title":"Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions","author":"Aydogan","year":"2012","journal-title":"Endocr. J., E"},{"issue":"21","key":"10.1016\/j.drugalcdep.2020.108255_bib0010","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108255_bib0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000081413","article-title":"Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample","volume":"11","author":"Berman","year":"2005","journal-title":"Eur. Addict res"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108255_bib0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.biopsych.2016.06.017","article-title":"Structural Brain Imaging of Long-Term Anabolic-Androgenic Steroid Users and Nonusing Weightlifters","volume":"82","author":"Bj\u00f8rnebekk","year":"2017","journal-title":"Biol. Psychiatry."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108255_bib0025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1037\/neu0000537","article-title":"Cognitive performance and structural brain correlates in long-term anabolic-androgenic steroid exposed and nonexposed weightlifters","volume":"33","author":"Bj\u00f8rnebekk","year":"2019","journal-title":"Neuropsychology."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108255_bib0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1360-0443.1991.tb03101.x","article-title":"Symptoms and correlates of anabolic\u2010androgenic steroid dependence","volume":"86","author":"Brower","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-020-00112-8","article-title":"Factors associated with drug use in prison\u2013results from the Norwegian offender mental health and addiction (NorMA) study","volume":"8","author":"Bukten","year":"2020","journal-title":"Health & Justice."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108255_bib0040","first-page":"59","article-title":"The Norwegian offender mental health and addiction study\u2013design and implementation of a national survey and prospective cohort study","volume":"9","author":"Bukten","year":"2015","journal-title":"Subst. Abuse."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108255_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13011-016-0056-3","article-title":"Recruitment to doping and help-seeking behavior of eight female AAS users","volume":"11","author":"B\u00f6rjesson","year":"2016","journal-title":"Subst. Abuse Treat. Prev. Policy."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108255_bib0050","first-page":"295","article-title":"Outline of a typology of men\u2019s use of anabolic androgenic steroids in fitness and strength training environments","volume":"24","author":"Christiansen","year":"2017","journal-title":"Drugs: Educ., Prev. and Policy."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2019.04.041","article-title":"Anabolic-androgenic steroids and the risk of imprisonment","volume":"203","author":"Christoffersen","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108255_bib0060","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.juro.2013.06.010","article-title":"Anabolic steroid induced hypogonadism in young men","volume":"190","author":"Coward","year":"2013","journal-title":"J Urol."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1677\/joe.0.1700055","article-title":"Drugs in sport - the role of the physician","volume":"170","author":"Dawson","year":"2001","journal-title":"J Endocrinol."},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2020.108255_bib0070","first-page":"100","article-title":"The use of anabolic androgenic steroids and polypharmacy: A review of the literature","volume":"114","author":"Dodge","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"9769","key":"10.1016\/j.drugalcdep.2020.108255_bib0075","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(10)61053-7","article-title":"The health of prisoners","volume":"377","author":"Fazel","year":"2011","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108255_bib0080","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S2215-0366(16)30142-0","article-title":"Mental health of prisoners: prevalence, adverse outcomes, and interventions","volume":"3","author":"Fazel","year":"2016","journal-title":"Lancet Psychiatry."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108255_bib0085","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/add.13877","article-title":"Substance use disorders in prisoners: an updated systematic review and meta\u2010regression analysis in recently incarcerated men and women","volume":"112","author":"Fazel","year":"2017","journal-title":"Addiction."},{"issue":"S1","key":"10.1016\/j.drugalcdep.2020.108255_bib0090","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1017\/S1047951116002274","article-title":"The role of illicit drug use in sudden death in the young","volume":"27","author":"Fischbach","year":"2017","journal-title":"Cardiol Young."},{"issue":"1-3","key":"10.1016\/j.drugalcdep.2020.108255_bib0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drugalcdep.2009.12.024","article-title":"Dual use of anabolic-androgenic steroids and narcotics in Sweden","volume":"109","author":"Garevik","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108255_bib0100","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/dar.12688","article-title":"Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users","volume":"37","author":"Griffiths","year":"2018","journal-title":"Drug Alcohol Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108255_bib0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000333037","article-title":"Anabolic androgenic steroids in the general population: User characteristics and associations with substance use","volume":"18","author":"Hakansson","year":"2012","journal-title":"Eur. Addict. Res."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108255_bib0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1176\/appi.psy.46.4.285","article-title":"Psychiatric Complications of Anabolic Steroid Abuse","volume":"46","author":"Hall","year":"2005","journal-title":"Psychosomatics."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0115","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00213-019-05239-7","article-title":"Anabolic androgenic steroid dependence is associated with impaired emotion recognition","volume":"236","author":"Hauger","year":"2019","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107874","article-title":"Anabolic androgenic steroid dependence is associated with executive dysfunction","volume":"208","author":"Hauger","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108255_bib0125","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/add.14629","article-title":"Structural brain characteristics of anabolic-androgenic steroid dependence in men","volume":"114","author":"Hauger","year":"2019","journal-title":"Addiction."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0130","article-title":"Anabolic-androgenic steroid use among women\u2013A qualitative study on experiences of masculinizing, gonadal and sexual effects","author":"Havnes","year":"2020","journal-title":"Int. J Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0135","article-title":"The anabolic androgenic steroid treatment gap: a national study of substance use disorder treatment","volume":"14","author":"Havnes","year":"2020","journal-title":"Subst Abuse."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108255_bib0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13011-019-0206-5","article-title":"Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires","volume":"14","author":"Havnes","year":"2019","journal-title":"Subst. Abuse Treat., Prev. Policy."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108255_bib0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003207","article-title":"Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study","volume":"3","author":"Hope","year":"2013","journal-title":"BMJ Open."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108255_bib0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/joim.12850","article-title":"Health consequences of androgenic anabolic steroid use","volume":"285","author":"Horwitz","year":"2019","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108255_bib0155","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1592\/phco.31.8.757","article-title":"The Anabolic 500 survey: Characteristics of male users versus nonusers of anabolic\u2010androgenic steroids for strength training","volume":"31","author":"Ip","year":"2011","journal-title":"Pharmacotherapy."},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108255_bib0160","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","article-title":"Anabolic\u2013androgenic steroid dependence: an emerging disorder","volume":"104","author":"Kanayama","year":"2009","journal-title":"Addiction."},{"issue":"1-3","key":"10.1016\/j.drugalcdep.2020.108255_bib0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.drugalcdep.2010.01.011","article-title":"Treatment of anabolic\u2013androgenic steroid dependence: Emerging evidence and its implications","volume":"109","author":"Kanayama","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108255_bib0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.v64n0208","article-title":"Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: An underrecognized problem?","volume":"64","author":"Kanayama","year":"2003","journal-title":"J. Clin. Psychiatry."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108255_bib0175","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/add.12850","article-title":"Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem","volume":"110","author":"Kanayama","year":"2015","journal-title":"Addiction."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108255_bib0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000505978","article-title":"Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians","volume":"89","author":"Kanayama","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neubiorev.2019.02.014","article-title":"Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Neurosci","volume":"100","author":"Kaufman","year":"2019","journal-title":"Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108255_bib0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/16066359709002968","article-title":"Drug use among prisoners before, during and after custody","volume":"4","author":"Keene","year":"1997","journal-title":"Addiction research"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108255_bib0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.comppsych.2009.05.007","article-title":"The significance of anabolic androgenic steroids in a Swedish prison population","volume":"51","author":"Kl\u00f6tz","year":"2010","journal-title":"Compr. Psychiatry."},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2020.108255_bib0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0379-0738(98)00159-5","article-title":"Drug abuse of Finnish male prisoners in 1995","volume":"97","author":"Korte","year":"1998","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0205","series-title":"Correctional Statistics of Denmark, Finland, Iceland, Norway and Sweden 2009-2013","author":"Kristoffersen","year":"2014"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108255_bib0210","article-title":"Patients who Seek Treatment for AAS Abuse in Sweden: Description of Characteristics","volume":"3","author":"Ljungdahl","year":"2019","journal-title":"J Addict. Med. Ther."},{"issue":"1-3","key":"10.1016\/j.drugalcdep.2020.108255_bib0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.forsciint.2012.01.004","article-title":"Anabolic androgenic steroids in police cases in Sweden 1999\u20132009","volume":"219","author":"Lood","year":"2012","journal-title":"Forensic Sci. International."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108255_bib0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/add.12715","article-title":"Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10 365 general population men","volume":"110","author":"Lundholm","year":"2015","journal-title":"Addiction."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108255_bib0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2010.04.020","article-title":"Use of anabolic androgenic steroids in substance abusers arrested for crime","volume":"111","author":"Lundholm","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108255_bib0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1176\/appi.ajp.2018.17040415","article-title":"Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects","volume":"176","author":"Mackey","year":"2019","journal-title":"Am. J. Psychiatry."},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108255_bib0235","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/add.12691","article-title":"Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15-49-year-old subjects: a forensic case-control study","volume":"109","author":"Morentin","year":"2014","journal-title":"Addiction."},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108255_bib0240","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.3390\/ijerph15122663","article-title":"Inmates with harmful substance use increase both exercise and nicotine use under incarceration","volume":"15","author":"Muller","year":"2018","journal-title":"Int. J. Environ. Res. Pub. Health."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0245","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2016.06.008","article-title":"Anabolic steroid use and body image psychopathology in men: delineating between appearance-versus performance-driven motivations","volume":"165","author":"Murray","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108255_bib0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/EJE-15-0080","article-title":"Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions","volume":"173","author":"Nieschlag","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0255","series-title":"About the Norwegian Correctional Service","author":"Norwegian Correctional Service","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0260","series-title":"Rusmestringsenheter (Substance Use Disorder treatment units)","author":"Norwegian Correctional Service","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0265","first-page":"313","article-title":"Use of doping agents and symptoms of eating disorders among male and female patients in drug addiction treatment","volume":"30","author":"N\u00f8kleby","year":"2013","journal-title":"Nord. Stud. Alcohol Drugs."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108255_bib0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11469-013-9434-5","article-title":"Body practices among male drug abusers. Meanings of workout and use of doping agents in a drug treatment setting","volume":"11","author":"N\u00f8kleby","year":"2013","journal-title":"Int. J. Ment. Health Addict."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108255_bib0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.drugalcdep.2005.07.001","article-title":"Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care: a controlled retrospective cohort study","volume":"81","author":"Petersson","year":"2006","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108255_bib0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2005.07.003","article-title":"Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids","volume":"81","author":"Petersson","year":"2006","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108255_bib0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","article-title":"Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review","volume":"13","author":"Piacentino","year":"2015","journal-title":"Curr. Neuropharmacology."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108255_bib0290","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108255_bib0295","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0010-440X(96)90013-9","article-title":"Anabolic-androgenic steroid use among 133 prisoners","volume":"37","author":"Pope","year":"1996","journal-title":"Compr. Psychiatry."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108255_bib0300","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid\u2013induced hypogonadism: diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108255_bib0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/HJH.0000000000001546","article-title":"Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?","volume":"36","author":"Rasmussen","year":"2018","journal-title":"J. Hypertens."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108255_bib0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161208","article-title":"Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108255_bib0315","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108255_bib0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/nsad-2015-0002","article-title":"Anabolic-androgenic steroid use in the Nordic countries: A meta-analysis and meta-regression analysis","volume":"32","author":"Sagoe","year":"2015","journal-title":"Nord. Stud. Alcohol Drugs."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugpo.2016.11.005","article-title":"The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use","volume":"40","author":"Santos","year":"2017","journal-title":"Int. J. Drug Policy."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0330","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2015.04.013","article-title":"Anabolic steroids and cardiovascular risk: a national population-based cohort study","volume":"152","author":"Thiblin","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108255_bib0335","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10401239909147074","article-title":"Anabolic androgenic steroids and suicide","volume":"11","author":"Thiblin","year":"1999","journal-title":"Ann. Clin. Psychiatry."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0340","series-title":"World Prison Brieaf. Highest to Lowest - Prison Population Rate","author":"WBF","year":"2020"},{"issue":"1-2","key":"10.1016\/j.drugalcdep.2020.108255_bib0345","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2008.01.027","article-title":"Acute myocardial infarction in young adults who abuse amphetamines","volume":"96","author":"Westover","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108255_bib0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugpo.2018.02.022","article-title":"Identifying a typology of men who use anabolic androgenic steroids (AAS)","volume":"55","author":"Zahnow","year":"2018","journal-title":"Int. J. Drug Policy."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:07:57Z","timestamp":1759828077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620304208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":70,"alternative-id":["S0376871620304208"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108255","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108255"}}